vendredi 7 avril 2017

Onco Actu du 7 avril 2017

1. Biologie

Study helps explain varying outcomes for cancer, Down Syndrome [MIT News]

Science Snaps: mapping cellular ‘stars’, one molecule at a time [Cancer Research UK]

2. Etiologie

Antibiotic use linked to 'pre-cancerous' bowel changes [NHS Choices]

2.6 Etiologie - Environnement

3 reasons why today’s headlines on breast cancer and air pollution are misleading [Cancer Research UK]

3.1.1 Tabac - e-cigs

Vaping shops selling to non-smokers [BBC News]

3.3 Prévention - Vaccins

Close to Half of American Adults Infected With HPV, Survey Finds [NY Times]

4.2 Dép., diag. & prono. - Génome

23andMe Rides Again: FDA Clears Genetic Tests To Predict Disease Risk [Forbes]

FDA OKs 23andMe’s Direct-to-Consumer Genetic Tests, With Caution [Xconomy]

FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions [FDA]

FDA Opens Genetic Floodgates with 23andMe Decision [MIT Technology Review]

FDA allows 23andMe to sell genetic tests for 10 diseases [Reuters]

23andMe given green-light to sell DNA tests for 10 diseases [Nature]

F.D.A. Will Allow 23andMe to Sell Genetic Tests for Disease Risk to Consumers [NY Times]

5.12.2 Immunothérapies - CAR-T

Kite Wins ‘Clinical Trial Result of the Year' for its Pivotal CAR-T Trial of Axicabtagene Ciloleucel in Patients with Aggressive Non-Hodgkin Lymphoma at the 2017 Clinical and Research Excellence Awards [Kite]

5.12.3 Immunothérapies-combinaisons

Nanoparticle-delivered combo boosts cancer immunotherapy [FierceBiotech]

5.2.3 Pharma - économie

BerGenBio completes IPO, raising $49M for cancer trials [FierceBiotech]

5.3 Traitements - FDA, EMA, NICE...

Study highlights the FDA’s speed in approving cancer drugs as a new commish looks to rev up reviews [EndPoints]

5.4 Traitements - Economie

How some news outlets help perpetuate drug industry price gouging [HealthNewsReview]

5.9 AACR

AACR Review: Biden Fired Up, Incyte Doubles Up, BMS Up And Down [Xconomy]

6. Lutte contre les cancers

Last Month in Oncology with Dr. Bishal Gyawali: March 2017 [ecancernews]

6.10.1 Politiques (USA)

NIH budget cuts will jeopardize America’s leadership in medical research [STAT]

A laboratory CEO on science funding, open-access publishing, and the future of genetics [STAT]

6.5 Médecines alternatives

Belle Gibson hit with $30,000 in court costs over false cancer claims [The Guardian]

6.6 Publications

Citations are more than merely assigning credit – their inclusion (or not) conditions how colleagues regard and evaluate your work [LSE]

Institute announces new open access policy for all MIT authors [MIT News]

Now free: citation data from 14 million papers, and more might come [Science]

Initiative aims to break science's citation paywall [Nature]

6.7.2 Applis

Can “Digital Therapeutics” Be as Good as Drugs? [MIT Technology Review]